financetom
Business
financetom
/
Business
/
Consortium aims to seal ESR buyout in coming weeks, likely valuing it at over $7 billion, say sources
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Consortium aims to seal ESR buyout in coming weeks, likely valuing it at over $7 billion, say sources
Nov 28, 2024 2:16 AM

HONG KONG (Reuters) - A consortium including Starwood Capital Group and Warburg Pincus aims to finalise a deal to take ESR Group ( ESRCF ) private in the coming weeks, valuing the Hong Kong-listed real estate fund manager at over $7 billion, said two sources.

The potential offer from the consortium, which according to ESR also includes its founders and a unit of sovereign wealth fund Qatar Investment Authority, would represent a premium of more than 18% over ESR's average share price over the past month of HK$11.06, according to Reuters calculations.

The sources, who have knowledge of the matter, declined to be named as the information was confidential.

Representatives for the consortium and Warburg declined to comment, while ESR did not respond to requests for comment.

Warburg Pincus, ESR's top shareholder with a 14% stake, plans to roll over its holdings into the future private company, rather than cash out, said the two sources and two other people with knowledge of the matter.

Terms of the deal, including the offer price, are not finalised, however, and can still change, the sources said.

ESR said in May it had received an initial proposal from a consortium led by Starwood Capital Group, Sixth Street Partners and SSW Partners, aiming to take the company private.

It said that proposal, received on April 25, would allow its shareholders to choose between receiving cash and rolling their shares into the new company, subject to the terms of the final roll-over arrangements. The consortium subsequently expanded to include Warburg Pincus and others.

The deal comes as ESR shares have fallen in the last couple of years amid China's property market slump. The stock is down over 60% from a 2021 peak, while the Hang Seng benchmark has fallen about a third during the period.

ESR manages a range of property-focused funds and its own property investments. It went public in Hong Kong in 2019 after pricing its initial public offering (IPO) at HK$16.8 per share, raising $1.6 billion.

In June, the group said it had received approval from China's securities regulator to list its logistics real estate firm in the country and expected to raise around 2.44 billion yuan ($336 million) from the listing.

That listing has yet to happen.

ESR was co-founded by its executives and private equity firm Warburg Pincus in Shanghai in 2011 and has expanded over the years via a string of acquisitions.

($1 = 7.7816 Hong Kong dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
3M Board Approves Planned Spin-off of Health Care Business
3M Board Approves Planned Spin-off of Health Care Business
Mar 8, 2024
12:17 PM EST, 03/08/2024 (MT Newswires) -- 3M ( MMM ) said Friday its board approved the planned spin-off of its health care business, which will be known as Solventum. Solventum, expected to separate on April 1, has applied to list on the New York Stock Exchange under the SOLV ticker. 3M ( MMM ) shareholders will receive one share...
What's Going On With Psyence Biomedical Stock?
What's Going On With Psyence Biomedical Stock?
Mar 8, 2024
Psyence Biomedical Ltd. ( PBM ) shares are racing higher Friday. The company recently announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study. The Details: On Wednesday, Psyence Biomedical ( PBM ) announced the approval for its Phase IIb study to examine the use of psilocybin as a treatment for Adjustment Disorder...
--Street Color: 3M Approves Spinoff of Health Care Business
--Street Color: 3M Approves Spinoff of Health Care Business
Mar 8, 2024
12:21 PM EST, 03/08/2024 (MT Newswires) -- (Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 94.07, Change: +1.45, Percent...
Why Bio-Path Holdings Shares Are Falling Today
Why Bio-Path Holdings Shares Are Falling Today
Mar 8, 2024
Bio-Path Holdings, Inc. ( BPTH )  shares are falling on Friday. The company reported fourth-quarter earnings per share of $4.23 loss, narrower than the estimate of $5.40 loss.  Bio-Path ( BPTH ) reported a net loss of $33.63 per share for the year ended Dec. 31, 2023, lower than $38.12 per share in the year-ago period. Research and development expense for the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved